See p 2285 colleagues8 analyze the effect of EDRF/NO in reactive hyperemia of the human forearm vasculature, and Gilligan and coworkers9 evaluate the contribution of EDRF/NO to exercise-induced vasodilation in the human forearm. NO is synthesized from L-arginine through the five-electron oxidation of this basic amino acid by the enzyme NO synthase, one isoform of which is constitutively expressed in endothelial cells. Using (local) brachial artery infusions of an inhibitor of this enzyme, NG-monomethyl-L-arginine (L-NMMA), these two groups of investigators examined the contribution of EDRF/NO synthesis to vascular responses in normal volunteers. Both studies demonstrated a 25% to 36% reduction in baseline blood flow during L-NMMA infusion and thus confirmed previous work suggesting an important contribution of EDRF/NO synthesis to resting arterial tone.6'10 Tagawa and colleagues8 demonstrated that after transient brachial artery occlusion, L-NMMA did not affect peak blood flow but significantly decreased the duration of hyperemia or flow debt repayment. Gilligan and coworkers9 observed that the absolute flow during forearm exercise was reduced modestly during L-NMMA infusion, although the relative increase in flow was in fact higher during infusions reflecting the reduction in baseline flow. Interpretation of their results is also complicated by the fact that L-NMMA increased systemic blood pressure and
Since its discovery by Furchgott and Zawadzki in 1980,1 endothelium-derived relaxing factor (EDRF) has been shown to play a central role in the cardiovascular system.2 This endothelial product is chemically equivalent to nitric oxide (NO)3'4 or a biochemical congener thereof,5 and relaxes vascular smooth muscle in association with activating guanylyl cyclase and increasing cGMP. Operating through this basic paradigm, EDRF/NO is a critical determinant of several normal physiological responses of the vascular system that are essential for the maintenance of tissue perfusion. 6, 7 In this issue and the forthcoming December issue of Circulation, the potential role of EDRF/NO in two related vascular responses is examined. Tagawa and See p 2285 colleagues8 analyze the effect of EDRF/NO in reactive hyperemia of the human forearm vasculature, and Gilligan and coworkers9 evaluate the contribution of EDRF/NO to exercise-induced vasodilation in the human forearm. NO is synthesized from L-arginine through the five-electron oxidation of this basic amino acid by the enzyme NO synthase, one isoform of which is constitutively expressed in endothelial cells. Using (local) brachial artery infusions of an inhibitor of this enzyme, NG-monomethyl-L-arginine (L-NMMA), these two groups of investigators examined the contribution of EDRF/NO synthesis to vascular responses in normal volunteers. Both studies demonstrated a 25% to 36% reduction in baseline blood flow during L-NMMA infusion and thus confirmed previous work suggesting an important contribution of EDRF/NO synthesis to resting arterial tone.6'10 Tagawa and colleagues8 demonstrated that after transient brachial artery occlusion, L-NMMA did not affect peak blood flow but significantly decreased the duration of hyperemia or flow debt repayment. Gilligan and coworkers9 observed that the absolute flow during forearm exercise was reduced modestly during L-NMMA infusion, although the relative increase in flow was in fact higher during infusions reflecting the reduction in baseline flow. Interpretation of their results is also complicated by the fact that L-NMMA increased systemic blood pressure and
The opinions expressed in this editorial comment are not necessarily those of the editors or of the American Heart Association. ©3 1994 American Heart Association, Inc. slightly decreased heart rate. It is possible that L-NMMA would have had a more marked effect with greater degrees of exercise than were achieved with hand grip in this study, and such a finding would be consistent with previous studies in animals. Thus, these studies provide convincing evidence that EDRF/NO synthesis contributes to basal arterial tone, to the postischemic hyperemic response, and, perhaps, modestly to the forearm exercise response.
Reactive hyperemia is a protective adaptation that has evolved in mammals to ensure prompt restoration of blood flow when flow is interrupted abruptly and ischemia is induced. Vascular physiologists have considered the mechanisms responsible for this response for many years and have invoked a role for both direct myogenic responses and for local vasoactive substances, among which are included prostaglandins, adenosine, potassium, adenosine 5'-triphosphate, oxygen, and pH," as well as hydrogen peroxide. 12 With the recognition that EDRF/NO is also an important endogenous vasodilator, investigators have recently begun to examine its role as well in reactive hyperemia. Most studies, all previously conducted in animals, support the view that EDRF/NO does contribute to the reactive hyperemic response and appears to do so in conjunction with other vasoactive agents previously considered essential for hyperemia. Importantly, the quantitative contribution that each of these agents or class of agents makes to the reactive hyperemic response appears to depend on the vascular bed studied, the experimental species used, and the mechanism by which ischemia or tissue hypoxia is produced.
Recent work from several groups supports the view that several of these locally active agents interact with EDRF/NO to promote reactive hyperemia. In the guinea pig coronary circulation, for example, Vials and Burnstock13 showed that while a major part of the vasodilatory action of adenosine is a consequence of the direct activation of A2-purinoceptors on the vascular smooth muscle, activation of a subpopulation of this same receptor class on endothelial cells induces vasorelaxation through production of EDRF/NO. Baker and Sutton14 confirmed this view using rat cremaster muscle preparations, showing further that luminal endothelial purinoreceptors cause arteriolar dilation by an EDRF/ NO-dependent mechanism, whereas abluminal (smooth muscle) purinoreceptors induce vasodilation by a mechanism independent of EDRF/NO. In the isolated guinea pig heart, Kostic 24 The increase in transcription may itself be shear-stress dependent, given the recent observations that endothelial products that increase in response to shear have in the 5'-untranslated regions of their genes a response element (GAGACC) that is shear sensitive25 and that nine of these shearstress response elements are present in the 5'-untranslated region of bovine endothelial NO synthase. 26 The findings of these studies also have important implications for control of blood flow in a number of pathological states where EDRF-dependent dilation of conduit and resistance vessels is known to be impaired. In contrast to the effects of these disease states on reactive hyperemia, the maximum flow response to increased oxygen demand is impaired in the setting of atherosclerosis. Nabel 
